Intravascular papillary endothelial hyperplasia (IPEH). Evidence supporting a piecemeal mode of angiogenesis from vein endothelium, with vein wall neovascularization and papillary formation.
Intravascular papillary endothelial hyperplasia (IPEH) is a reactive process of questioned pathogenesis (primary proliferation of endothelial cells/ECs versus organizing thrombi). The aim of this study is to assess the organization of morphologic patterns, with precise location of neovascularization and papillary distribution in IPEH to clarify the role of the vein wall (mainly vein intimal ECs) in lesion development and papillary formation. We studied 12 cases of IPEH in skin and subcutaneous veins by serial histological sections and immunohistochemical procedures. In four well-structured cases (the remaining cases showed overlapping events), we found four principal histological patterns organized by zone: 1) invaginated vein wall zone with microvascular networks. The intraparietal microvessels presented CD34+ and CD31+ ECs arising from ECs of the vein intima, and αSMA+ pericyte-like cells originating from modified SMCs of the media layer. 2) Papillary zone, generally with myriad papillae, formed by ECs of intraparietal microvessel networks encircling vein wall components (parietal papillae). 3) Organizing thrombotic zone from microvascular networks of invaginated vein wall zone. 4) Unorganized thrombotic zone partially covered by ECs, also originating from vein intimal endothelium and arranged in a monolayer or encircling thrombotic fibrin (thrombotic papillae). In conclusion, the capacity of vein intimal ECs and those originating from them (in newly-formed microvessels in the vein itself and covering the unorganized thrombi) to encircle vein wall components or fibrin, and to form papillae (ECs form the cover and encircled components the core) supports a piecemeal mode of angiogenesis as a pathogenic basis of IPEH. This mechanism encompasses the two histogenetic hypotheses outlined above.
Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, La Laguna, Tenerife, Spain. Kayto54@gmail.com.
L
L
Díaz-Flores
Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, La Laguna, Tenerife, Spain.
R
R
Gutiérrez
Department of Cell Biology and Histology, School of Medicine, Regional Campus of International Excellence, "Campus Mare Nostrum", IMIB-Arrixaca, University of Murcia, Murcia, Spain.
J F
JF
Madrid
Department of Pathology, Hospiten® Hospitals, Tenerife, Spain.
M P
MP
García-Suárez
Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, La Laguna, Tenerife, Spain.
M P
MP
González-Álvarez
Department of Physical Medicine and Pharmacology, Faculty of Medicine, University of La Laguna, La Laguna, Tenerife, Spain.
L
L
Díaz-Flores
Deparment of Cell Biology and Histology, UFI11/44, School of Medicine and Dentistry, University of the Basque Country, UPV/EHU, Leioa, Spain.
F J
FJ
Sáez
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D042783:Endothelial Cells / Q000473:pathology*; D004730:Endothelium, Vascular / Q000473:pathology*; D005260:Female; D006801:Humans; D006965:Hyperplasia / Q000473:pathology; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000473:pathology*; D014680:Veins / Q000473:pathology*; D055815:Young Adult